News | August 16, 2023
Exor to buy 15% shareholding in Philips
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Newcastle University’s Dr Srikanth Ramaswamy has been announced as one of six new Fellows selected for the 2023 Lister prize
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
Abbott India has reported total income of Rs. 1535 crores during the period ended June 30, 2023
Several crucial provisions to elevate the standards of nursing education and services, enhance professional conduct, and ensure greater transparency and accountability introduced
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
The instrument is fully integrated with Lonza’s latest WinKQCLSoftware to enable data integrity compliance, streamline training, and reduce validation burden
Subscribe To Our Newsletter & Stay Updated
